Susquehanna International Group’s BioLineRX BLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $50.7K | Buy |
+11,098
| New | +$50.7K | ﹤0.01% | 6029 |
|
|
2025
Q1 | – | Sell |
-2,180
| Closed | -$18.5K | – | 6435 |
|
|
2024
Q4 | $18.5K | Buy |
2,180
+1,729
| +383% | +$14.7K | ﹤0.01% | 6007 |
|
|
2024
Q3 | $9.67K | Sell |
451
-2,504
| -85% | -$53.7K | ﹤0.01% | 5470 |
|
|
2024
Q2 | $66.9K | Sell |
2,955
-2,168
| -42% | -$49.1K | ﹤0.01% | 5213 |
|
|
2024
Q1 | $230K | Buy |
5,123
+1,873
| +58% | +$83.9K | ﹤0.01% | 4529 |
|
|
2023
Q4 | $204K | Sell |
3,250
-2,683
| -45% | -$168K | ﹤0.01% | 4984 |
|
|
2023
Q3 | $432K | Buy |
5,933
+3,831
| +182% | +$279K | ﹤0.01% | 3615 |
|
|
2023
Q2 | $134K | Buy |
+2,102
| New | +$134K | ﹤0.01% | 4863 |
|
|
2022
Q2 | – | Sell |
-875
| Closed | -$60K | – | 5835 |
|
|
2022
Q1 | $60K | Sell |
875
-881
| -50% | -$60.4K | ﹤0.01% | 5272 |
|
|
2021
Q4 | $143K | Sell |
1,756
-186
| -10% | -$15.1K | ﹤0.01% | 5155 |
|
|
2021
Q3 | $212K | Buy |
+1,942
| New | +$212K | ﹤0.01% | 4650 |
|
|
2019
Q2 | – | Sell |
-128
| Closed | -$33K | – | 4519 |
|
|
2019
Q1 | $33K | Sell |
128
-78
| -38% | -$20.1K | ﹤0.01% | 2809 |
|
|
2018
Q4 | $54K | Buy |
+206
| New | +$54K | ﹤0.01% | 3314 |
|
|
2018
Q3 | – | Sell |
-180
| Closed | -$98K | – | 3429 |
|
|
2018
Q2 | $98K | Buy |
+180
| New | +$98K | ﹤0.01% | 3292 |
|
|
2017
Q3 | – | Sell |
-247
| Closed | -$126K | – | 3216 |
|
|
2017
Q2 | $126K | Sell |
247
-2,157
| -90% | -$1.1M | ﹤0.01% | 3205 |
|
|
2017
Q1 | $1.39M | Buy |
+2,404
| New | +$1.39M | ﹤0.01% | 1361 |
|
|
2016
Q4 | – | Sell |
-81
| Closed | -$56K | – | 4176 |
|
|
2016
Q3 | $56K | Buy |
+81
| New | +$56K | ﹤0.01% | 2762 |
|
|
2016
Q2 | – | Sell |
-65
| Closed | -$40K | – | 3224 |
|
|
2016
Q1 | $40K | Buy |
+65
| New | +$40K | ﹤0.01% | 3670 |
|